blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2747772

EP2747772 - OPHTHALMIC FORMULATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.06.2016
Database last updated on 05.10.2024
Most recent event   Tooltip19.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 21.11.2018  [2018/47]
Applicant(s)For all designated states
Altacor Limited
St Johns Innovation Centre
Cowley Road
Cambridge, Cambridgeshire CB4 0WS / GB
[2014/27]
Inventor(s)01 / CRAWFORD, Francesca
Altacor Limited
St. John's Innovation Centre
Cowley Road
Cambridge CB4 0WS / GB
02 / GUNNING, Philip
Altacor Limited
St. John's Innovation Centre
Cowley Road
Cambridge CB4 0WS / GB
 [2014/27]
Representative(s)Teuten, Andrew John, et al
Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
[N/P]
Former [2014/27]Teuten, Andrew John, et al
Sagittarius IP
Three Globeside
Fieldhouse Lane
Marlow, Buckinghamshire SL7 1HZ / GB
Application number, filing date12762365.024.08.2012
WO2012GB52082
Priority number, dateGB2011001472525.08.2011         Original published format: GB 201114725
[2014/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013027065
Date:28.02.2013
Language:EN
[2013/09]
Type: A1 Application with search report 
No.:EP2747772
Date:02.07.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 28.02.2013 takes the place of the publication of the European patent application.
[2014/27]
Type: B1 Patent specification 
No.:EP2747772
Date:05.08.2015
Language:EN
[2015/32]
Search report(s)International search report - published on:EP28.02.2013
ClassificationIPC:A61K31/79, A61K33/18, A61K47/38, A61K9/00, A61K9/08, A61K9/12, A61P31/00, A61P31/04, A61P31/10
[2015/02]
CPC:
A61K31/79 (EP,US); A61K33/18 (EP,US); A61K47/38 (EP,US);
A61K9/0048 (EP,US); A61P31/00 (EP); A61P31/04 (EP);
A61P31/10 (EP) (-)
C-Set:
A61K31/79, A61K2300/00 (EP,US);
A61K33/18, A61K2300/00 (US,EP)
Former IPC [2014/27]A61K31/79, A61K9/00, A61K33/18
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/27]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:OPHTHALMIKUM[2015/02]
English:OPHTHALMIC FORMULATIONS[2014/27]
French:FORMULATION OPHTALMIQUE[2015/02]
Former [2014/27]OPHTHALMISCHE FORMULIERUNGEN
Former [2014/27]PRÉPARATIONS OPHTALMIQUES
Entry into regional phase13.03.2014National basic fee paid 
13.03.2014Designation fee(s) paid 
13.03.2014Examination fee paid 
Examination procedure13.03.2014Examination requested  [2014/27]
25.09.2014Amendment by applicant (claims and/or description)
26.02.2015Communication of intention to grant the patent
26.06.2015Fee for grant paid
26.06.2015Fee for publishing/printing paid
26.06.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.02.2015
Opposition(s)09.05.2016No opposition filed within time limit [2016/28]
Fees paidRenewal fee
04.08.2014Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.08.2012
AL05.08.2015
AT05.08.2015
BG05.08.2015
CY05.08.2015
CZ05.08.2015
DK05.08.2015
EE05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
MC05.08.2015
MK05.08.2015
MT05.08.2015
PL05.08.2015
RO05.08.2015
RS05.08.2015
SI05.08.2015
SK05.08.2015
SM05.08.2015
TR05.08.2015
LU24.08.2015
CH31.08.2015
LI31.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
[2018/47]
Former [2018/31]HU24.08.2012
AT05.08.2015
BG05.08.2015
CY05.08.2015
CZ05.08.2015
DK05.08.2015
EE05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
MC05.08.2015
MK05.08.2015
MT05.08.2015
PL05.08.2015
RO05.08.2015
RS05.08.2015
SI05.08.2015
SK05.08.2015
SM05.08.2015
TR05.08.2015
LU24.08.2015
CH31.08.2015
LI31.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2018/02]HU24.08.2012
AT05.08.2015
BG05.08.2015
CY05.08.2015
CZ05.08.2015
DK05.08.2015
EE05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
MC05.08.2015
MT05.08.2015
PL05.08.2015
RO05.08.2015
RS05.08.2015
SI05.08.2015
SK05.08.2015
SM05.08.2015
LU24.08.2015
CH31.08.2015
LI31.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2017/39]HU24.08.2012
AT05.08.2015
BG05.08.2015
CY05.08.2015
CZ05.08.2015
DK05.08.2015
EE05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
MC05.08.2015
MT05.08.2015
PL05.08.2015
RO05.08.2015
RS05.08.2015
SI05.08.2015
SK05.08.2015
SM05.08.2015
CH31.08.2015
LI31.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2017/22]AT05.08.2015
CZ05.08.2015
DK05.08.2015
EE05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
MC05.08.2015
MT05.08.2015
PL05.08.2015
RO05.08.2015
RS05.08.2015
SI05.08.2015
SK05.08.2015
CH31.08.2015
LI31.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2016/36]AT05.08.2015
CZ05.08.2015
DK05.08.2015
EE05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
MC05.08.2015
PL05.08.2015
RO05.08.2015
RS05.08.2015
SI05.08.2015
SK05.08.2015
CH31.08.2015
LI31.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2016/26]AT05.08.2015
CZ05.08.2015
DK05.08.2015
EE05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
MC05.08.2015
PL05.08.2015
RO05.08.2015
RS05.08.2015
SK05.08.2015
CH31.08.2015
LI31.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2016/23]AT05.08.2015
CZ05.08.2015
DK05.08.2015
EE05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
PL05.08.2015
RO05.08.2015
RS05.08.2015
SK05.08.2015
CH31.08.2015
LI31.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2016/22]AT05.08.2015
CZ05.08.2015
DK05.08.2015
EE05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
PL05.08.2015
RS05.08.2015
CH31.08.2015
LI31.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2016/20]AT05.08.2015
DK05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
PL05.08.2015
RS05.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2016/11]AT05.08.2015
FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
PL05.08.2015
RS05.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2016/10]FI05.08.2015
HR05.08.2015
LT05.08.2015
LV05.08.2015
PL05.08.2015
RS05.08.2015
NO05.11.2015
GR06.11.2015
IS05.12.2015
PT07.12.2015
Former [2016/09]FI05.08.2015
LT05.08.2015
LV05.08.2015
NO05.11.2015
GR06.11.2015
Former [2016/08]LT05.08.2015
NO05.11.2015
Former [2016/07]LT05.08.2015
Cited inInternational search[A]EP0476777  (DAGRA PHARMA BV [NL]) [A] 1-28 * the whole document * * column 3, line 12 - line 21 * * example 1 * * claims 1,4-9 *;
 [A]US5126127  (BHAGWAT DILEEP [US], et al) [A] 1-28 * the whole document * * column 1, line 66 - column 2, line 23 * * column 6, line 9 - line 16 * * column 6, line 44 - line 52 * * column 7, line 18 - line 35 * * example 1 *
by applicantUS5849291
 WO2007106381
 WO2009097123
 US5232692
 US4364929
 US4954351
 US5709851
 US5643608
 US5178853
 US4976969
 US5126127
 WO2004064804
    - GHOSH ET AL., ANAESTHESIA, (2006), vol. 61, pages 1116 - 1129
    - ISENBERG ET AL., COMMUNITY EYE HEALTH, (2003), vol. 16, pages 30 - 31
    - FERGUSON ET AL., BRITISH JOURNAL OF OPHTHALMOLOGY, (2003), vol. 87, pages 163 - 167
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.